Generalized epilepsy with tonic-clonic seizures

There are 2 papers on generalized epilepsy with tonic-clonic seizures in aging research: 2 observational studies in people.

Disease

2 papers study it2 findings

See all 2 papers on generalized epilepsy with tonic-clonic seizures

“Inhibition of Niemann-Pick C1-Like 1 corresponded to a lower risk of generalized epilepsy with tonic-clonic seizures (OR = 0.98; 95% CI: 0.97-0.98; P = 1.2 × 10-34)”
Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization studyMedicine2026doi:10.1097/md.0000000000048021
  • Humans2

Associations

2

PCSK9 inhibitors

downin humans1OR 0.99

1 study
  1. PCSK9 inhibitors are linked with a lower risk of generalized epilepsy with tonic-clonic seizures in humans (genetically proxied PCSK9 inhibition (Mendelian randomization)) (OR 0.99 (95% CI 0.98–1.00); P = 1.4 × 10-2).

    Humansgenetically proxied PCSK9 inhibition (Mendelian randomization)

More on PCSK9 inhibitors

Ezetimibe

downin humans1OR 0.98

1 study
  1. Ezetimibe is linked with a lower risk of generalized epilepsy with tonic-clonic seizures in humans (genetically proxied NPC1L1 inhibition (Mendelian randomization)) (OR 0.98 (95% CI 0.97–0.98); P = 1.2 × 10-34).

    Humansgenetically proxied NPC1L1 inhibition (Mendelian randomization)

More on Ezetimibe

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months